E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells

Cellular Oncology

Volumn 37, Issue 6, 2014, Pages 409-419

  Rawat, Akhilesh ^a   Gopisetty, Gopal ^a   Thangarajan, Rajkumar ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

5 Aza dC; Breast cancer; E4BP4; Epigenetic; Methylation; SOSTDC1

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; NFIL3 PROTEIN, HUMAN; PROTEIN; SOSTDC1 PROTEIN, HUMAN;

BREAST TUMOR; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HEK293 CELL LINE; HUMAN; MCF 7 CELL LINE; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MCF-7 CELLS; PROTEINS;

EID: 84914178667     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-014-0204-6     Document Type: Article

References (16)

1. S. Tabarestani, S.M. Ghaderian, H. Rezvani, R. Mirfakhraie, A. Ebrahimi, H. Attarian, J. Rafat, M. Ghadyani, H.A. Alavi, N. Kamalian, A. Rakhsha, E. Azargashb, Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification. Cell. Oncol. 37, 107–118 (2014)
2. A. Rawat, G. Gopal, G. Selvaluxmy, T. Rajkumar, Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole. Cell. Oncol. 36, 459–67 (2013)
3. A. Geurts van Kessel, The cancer genome: from structure to function. Cell. Oncol. 37, 155–165 (2014)
4. J.S. de Groot, X. Pan, J. Meeldijk, E. van der Wall, P.J. van Diest, C.B. Moelans, Validation of DNA promoter hypermethylation biomarkers in breast cancer–a short report. Cell. Oncol. 37, 297–303 (2014)
5. E. Dulaimi, J. Hillinck, I. de Caceres Ibanez, T. Al-Saleem, P. Cairns, Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin. Cancer Res. 10, 6189–6193 (2004)
6. X. Yang, L. Yan, N.E. Davidson, DNA methylation in breast cancer. Endocr Relat Cancer. 8, 115–127 (2001)
7. T.X. Xiang, Y. Yuan, L. Li, Z.H. Wang, L.Y. Dan, G.S. Chen Ren, Q. Tao, Aberrant promoter CpG methylation and its translational applications in breast cancer. Chin J Cancer. 30, 12–20 (2013)
8. K.A. Clausen, K.R. Blish, C.E. Birse, M.A. Triplette, T.E. Kute, G.B. Russell, R.B. D’Agostino Jr., L.D. Miller, F.M. Torti, S.V. Torti, SOSTDC1 differentially modulates Smad and beta–catenin activation and is down–regulated in breast cancer. Breast Cancer Res. Treat. 129, 737–746 (2010)
9. K.R. Blish, W. Wang, W.M.C. Du, C.E. Birse et al., A human bone morphogenetic protein antagonist is down-regulated in renal cancer. Mol. Biol. Cell 19, 457–464 (2008)
10. G. Gopal, U.M. Raja, S. Shirley, K.R. Rajalekshmi, T. Rajkumar, SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer. Cancer Genet. 206, 174–182 (2013)
11. I.G. Cowell, H.C. Hurst, Protein-protein interaction between the transcriptional repressor E4BP4 and the TBP-binding protein Dr1. Nucleic Acids Res. 24, 3607–3613 (1996)
12. I.G. Cowell, A. Skinner, H.C. Hurst, Transcriptional repression by a novel member of the bZIP family of transcription factors. Mol. Cell. Biol. 12, 3070–3077 (1992)
13. T. Rajkumar, N. Vijayalakshmi, G. Gopal, K. Sabitha, S. Shirley, U.M. Raja, S.A. Ramakrishnan, Identification and validation of genes involved in gastric tumorigenesis. Cancer Cell Int. 10(45), 1475–2867 (2010). 10-45
14. S. Ammanamanchi, M.G. Brattain, Sp3 is a transcriptional repressor of transforming growth factor-beta receptors. J. Biol. Chem. 276, 3348–3352 (2001)
15. N.H. Nabilsi, R.R. Broaddus, D.S. Loose, DNA methylation inhibits p53-mediated survivin repression. Oncogene 28, 2046–2050 (2009)
16. I.G. Cowell, E4BP4/NFIL3, a PAR-related bZIP factor with many roles. Bioessays 24, 1023–1029 (2002)